Anti-dengue performance panel
The first commercially available Anti-Dengue Mixed Titer Performance Panel has been launched by SeraCare. It is designed to help blood donor collection facilities, diagnostics manufacturers and clinical laboratories evaluate and troubleshoot their anti-dengue virus assays. The new performance panel is derived from undiluted, unpreserved human plasma specimens, with 21 members representing a wide range of reactivity for anti-dengue IgM and IgG antibodies, from negative to strongly positive. Panel members include samples from individuals with recent and past infection by all four dengue viruses (DENV-1 through DENV-4).
Supplier: SeraCare Life Sciences
Website:
